Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Herbal acupuncture needles aim to ease Crash-Related knee pain

NCT ID NCT06931951

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding herbal acupuncture to standard oriental medicine treatments can better relieve acute knee pain from traffic accidents. Forty adults hospitalized with knee pain (rated 5 or higher on a 0-10 scale) will be randomly assigned to receive either herbal acupuncture plus standard care or standard care alone. The main goal is to see if the herbal acupuncture group reports less pain after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
herbal extract-based pharmacopuncture (injected into acupuncture points)
What this could lead to
If it works, this could offer a non-drug option for quickly easing knee pain after a car accident.
What could go wrong
This is a very small pilot study with only 40 people, so results may not apply widely. It compares two similar treatments, so a big difference is unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 69 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * When the NRS (Numeric Rating Scale) of knee pain caused by a traffic accident is 5 or higher. * Patients hospitalized for traffic accident treatment. * Patients with acute pain within 14 days of experiencing knee pain due to a traffic accident. * Patients aged between 19 and 70 years old. * participants who agree to participate in clinical research and provide written test subject consent. Exclusion Criteria: * For patients diagnosed with a specific serious disease that may cause knee pain (acute fracture, dislocation, complete rupture of ligaments, etc.) * If the cause of the pain is caused by a disease other than the knee (tumor, fibromyalgia, rheumatoid arthritis, gout, lumbar disc herniation, etc.) * Cases where surgical intervention is required due to suspected acute fracture, dislocation, or ligament and cartilage damage * If there is another acute disease (stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with the treatment effect or interpretation of results * Patients currently taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect their findings * Inadequate or unsafe medication: hemorrhagic disease, anticoagulant therapy, severe diabetic patients with risk of infection * Patients who have taken drugs that may affect pain, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or have received herbal acupuncture or physical therapy within the past week * In the case of pregnant women and in the case of planning to become pregnant or nursing * Patients within 3 months after knee surgery or if knee replacement surgery was performed * If it has been less than 1 month since participants finished participating in another clinical study, or if participants are planning to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection * If it is difficult to fill out the consent form for research participation * In cases where it is difficult for other researchers to participate in clinical research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pharmacologic action are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Daejeon Jaseng Hospital of Korean Medicine

    RECRUITING

    Daejeon, South Korea